Showing 151-160 of 308 results for "".
Tax-Loss Harvesting: A Timely Strategy in All Markets
https://modernaesthetics.com/ma-issues-index/2023-nov-dec/tax-loss-harvesting-a-timely-strategy-in-all-markets/35335/Your practice can leverage an accounting analysis and report to protect and drive valueThe State of the Facelift: From Passé to Premium
https://modernaesthetics.com/ma-issues-index/2023-sept-oct/the-state-of-the-facelift-from-passe-to-premium/35312/An Interview With Neil A. Gordon, MD, Steven R. Gordon, MD, and Ben Talei, MDUltraClear from Acclaro
https://modernaesthetics.com/topics/energy-based-devices/ultraclear-from-acclaro/35201/Toward Racial and Ethnic Equality in Aesthetic Practice, Part 2
https://modernaesthetics.com/topics/minimally-invasive/toward-racial-and-ethnic-equality-in-aesthetic-practice-part-2/34942/Part two of a series continues a dialogue about challenges and opportunities in aesthetic medicine.From Neglect to Nuance
https://modernaesthetics.com/ma-issues-index/july-august-2025/from-neglect-to-nuance-bridging-the-gaps-in-womens-health-and-wellness/36470/Bridging the gaps in women's health and wellnessThe Impact of Rising Costs on the Aesthetics Industry
https://modernaesthetics.com/ma-issues-index/2024-mar-apr/the-impact-of-rising-costs-on-the-aesthetics-industry/35362/Navigating Daxxify’s Potential in the Aesthetic Landscape
https://modernaesthetics.com/topics/injectables/navigating-daxxifys-potential-in-the-aesthetic-landscape/35294/Daxxify’s recent FDA approval provides practitioners with a neuromodulator option possessing a unique formulation and long-lasting results.I Just Received an Offer from a Private Equity Firm. What Should I Do Now?
https://modernaesthetics.com/topics/practice-development/i-just-received-an-offer-from-a-private-equity-firm-what-should-i-do-now/35206/Why you need a knowledgeable transaction advisor when considering a private equity deal.A Quick Guide to Aesthetic Neuromodulators
https://modernaesthetics.com/topics/injectables/a-quick-guide-to-aesthetic-neuromodulators/34998/This reference is an easy resource for the growing neuromodulators market.It’s Time to Reassess Breast Implantation… and Explantation
https://modernaesthetics.com/topics/surgical/its-time-to-reassess-breast-implantation-and-explantation/34921/As surgeons, we face a lack of definitive agreement on several emerging patient concerns. Open dialogue and patient education are essential.